Although Act1 is necessary for IL-17-mediated inflammation, Act1-deficient mice develop spontaneous SLE and Sjögren-like diseases (Li, 2008; Zhang et al., 2018). This evidence concerns the gene IL17A and systemic lupus erythematosus.